{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:47:15Z","timestamp":1792014435220,"version":"4.4.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>De novo<\/jats:italic>\n                      donor-specific HLA antibodies (dnDSAs) after kidney transplantation arise through coordinated antigen recognition, T-cell\u2013dependent B-cell activation, and subsequent germinal center reactions. Donor\u2013recipient HLA molecular mismatch reflects donor-derived antigenic disparity and is associated with dnDSA development; however, it does not fully explain interindividual variability in humoral alloimmune responses. We hypothesized that integrating HLA molecular mismatch with recipient T follicular helper (Tfh) cell-related immunogenetic variation would improve risk stratification and provide additional insight into variability in alloantibody responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective single-center cohort study, we analyzed 210 kidney transplant recipients who underwent transplantation between 2011 and 2024. Donor\u2013recipient HLA molecular mismatch loads were quantified using eplet mismatch analysis, Predicted Indirectly ReCognizable HLA Epitopes\u2013T cell (PIRCHE-T2), and HLA Epitope Mismatch Algorithm (HLA-EMMA). Recipient single-nucleotide polymorphisms in Tfh-related genes (\n                      <jats:italic>CXCR5<\/jats:italic>\n                      rs3922 and\n                      <jats:italic>CTLA4<\/jats:italic>\n                      rs231775) were genotyped. The primary endpoint was class II dnDSA development, defined as newly detected donor-specific antibodies with a normalized mean fluorescence intensity &amp;gt;1, 000 and persistence confirmed at least six months later. Associations between candidate variables and class II dnDSA development were assessed using Firth penalized logistic regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, 20 recipients (9.5%) developed class II dnDSAs. Higher class II molecular mismatch loads were significantly associated with dnDSA development, with HLA-EMMA showing the strongest association among the evaluated metrics. In multivariable analysis, high HLA-EMMA class II load and Tfh cell-related immunogenetic variation were independently associated with class II dnDSA development. Recipients with both high HLA-EMMA class II load and Tfh-related polymorphisms showed the highest cumulative incidence of dnDSA development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that donor-derived structural antigenicity and recipient Tfh-related immunogenetic variation are associated with the development of class II dnDSAs after kidney transplantation. The identified thresholds and integrated risk stratification approach are exploratory and require validation in independent cohorts before clinical application of the model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1875029","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:21:21Z","timestamp":1783311681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Donor\u2013recipient HLA molecular mismatch and T follicular helper-related genetic variants are associated with dnDSA development after kidney transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Hidetoshi","family":"Shidahara","sequence":"first","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Section of Clinical Laboratory, Department of Clinical Support, Hiroshima University Hospital","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Imaoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tahara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University","place":["Hiroshima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182543950","article-title":"De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy","volume":"94","author":"Willicombe","year":"2012","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13834","article-title":"What happens after graft loss? A large, long-term, single-center observation","volume":"34","author":"Schrezenmeier","year":"2021","journal-title":"Transpl Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.090501.112049","article-title":"Molecular mechanism of class switch recombination: linkage with somatic hypermutation","volume":"20","author":"Honjo","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.humimm.2006.10.003","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP","volume":"68","author":"Duquesnoy","year":"2007","journal-title":"Hum Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.12.004","article-title":"Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation","volume":"74","author":"Otten","year":"2013","journal-title":"Hum Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14393","article-title":"Donor-recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of de novo donor-specific HLA antibodies following renal transplantation","volume":"17","author":"Lachmann","year":"2017","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00321","article-title":"PIRCHE-II is related to graft failure after kidney transplantation","volume":"9","author":"Geneugelijk","year":"2018","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020010019","article-title":"Eplet mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, rejection, and graft failure after kidney transplantation: an observational cohort study","volume":"31","author":"Senev","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.10.028","article-title":"Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss","volume":"97","author":"Sapir-Pichhadze","year":"2020","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/tan.13883","article-title":"HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level","volume":"96","author":"Kramer","year":"2020","journal-title":"HLA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.623276","article-title":"Donor\/recipient HLA molecular mismatch scores predict primary humoral and cellular alloimmunity in kidney transplantation","volume":"11","author":"Meneghini","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102145","article-title":"Association of PIRCHE-II score with anti-donor T-cell response and risk of de novo donor-specific antibody production in kidney transplant recipients","volume":"87","author":"Yamane","year":"2024","journal-title":"Transpl Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MOT.0000000000000714","article-title":"Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients","volume":"25","author":"Wiebe","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13192","article-title":"HLA epitopes as viewed by antibodies: what is it all about","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coi.2016.08.003","article-title":"T follicular helper cells in human autoimmunity","volume":"43","author":"Ueno","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000715","article-title":"Follicular T-cell regulation of alloantibody formation","volume":"25","author":"Mohammed","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-065X.1996.tb00925.x","article-title":"CTLA-4, a negative regulator of T-lymphocyte activation","volume":"153","author":"Waterhouse","year":"1996","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2022.03.008","article-title":"Polymorphisms in CTLA-4 predict de novo donor specific antibody formation after kidney transplantation","volume":"83","author":"Ono","year":"2022","journal-title":"Hum Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111103","article-title":"Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantation","volume":"85","author":"Ono","year":"2024","journal-title":"Hum Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1994.tb02375.x","article-title":"Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals","volume":"44","author":"Hashimoto","year":"1994","journal-title":"Tissue Antigens"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/TXD.0000000000000526","article-title":"A phased desensitization protocol with rituximab and bortezomib for highly sensitized kidney transplant candidates","volume":"1","author":"Ide","year":"2015","journal-title":"Transplant Direct"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2023.03.016","article-title":"Genetic polymorphisms in follicular helper T cell-related molecules predispose patients to de novo donor-specific antibody formation after kidney transplantation","volume":"55","author":"Ono","year":"2023","journal-title":"Transplant Proc"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.04.013","article-title":"Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation","volume":"77","author":"Morimoto","year":"2016","journal-title":"Hum Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.10.026","article-title":"Time-unrestricted, immune surveillance-guided desensitization enables kidney transplantation in highly sensitized patients","volume":"11","author":"Ide","year":"2026","journal-title":"Kidney Int Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001887","article-title":"Terasaki epitope mismatch burden predicts the development of de novo DQ donor-specific antibodies and are associated with adverse allograft outcomes","volume":"102","author":"Willicombe","year":"2018","journal-title":"Transplantation"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.02.019","article-title":"Application of HLA molecular level mismatching in ethnically diverse kidney transplant recipients receiving a steroid-sparing immunosuppression protocol","volume":"24","author":"Santos","year":"2024","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548934","article-title":"Advancing risk stratification in kidney transplantation: integrating HLA-derived T-cell epitope and B-cell epitope matching algorithms for enhanced predictive accuracy of HLA compatibility","volume":"16","author":"Niemann","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508796","article-title":"De novo donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment","volume":"16","author":"Chou-Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.064","article-title":"Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine","volume":"32","author":"Duan","year":"2014","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-014-0157-0","article-title":"The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"Diagn Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12020-013-9985-z","article-title":"Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto\u2019s thyroiditis susceptibility: a meta-analysis","volume":"45","author":"Qiu","year":"2014","journal-title":"Endocrine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1875029\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:21:22Z","timestamp":1783311682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1875029\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2026.1875029"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1875029","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1875029"}}